ALEXANDRE TUNGESVIK, M.D.
Hematology & Oncology Physician · COLUMBIA, MO
Individual Active NPI 1538691381
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 919 | 214,087 | $16,342,026 | $4,930,137 | $3,918,949 |
| 2023 | 499 | 88,920 | $5,745,748 | $1,676,522 | $1,335,827 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 32,400 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 23,000 | $56 | $45 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 15,000 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 10,270 | $2 | $1 |
| J0897 | Injection, denosumab, 1 mg | 8,280 | $26 | $21 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 7,200 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 6,840 | $49 | $39 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 6,300 | $13 | $10 |
| J9299 | Injection, nivolumab, 1 mg | 5,780 | $31 | $25 |
| J9267 | Injection, paclitaxel, 1 mg | 4,336 | $0 | $0 |
| J1930 | Injection, lanreotide, 1 mg | 2,880 | $48 | $38 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,800 | $20 | $16 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 2023011840 | MO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Missouri
- NPI 1194342576
- NPI 1881688679
- NPI 1851654818
- NPI 1457921264
- NPI 1922404367
- NPI 1891284030
- NPI 1568548824
- NPI 1568886273
See all Hematology & Oncology Physician providers in Missouri →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.